Venus Remedies Limited
NSE:VENUSREM.NS
343.5 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,014.5 | 5,555.1 | 5,986.497 | 5,481.235 | 3,366.32 | 3,174.159 | 3,694.566 | 3,962.604 | 4,149.394 | 4,634.615 | 5,363.235 | 4,679.426 | 4,098.384 | 3,640.74 | 3,146.116 | 2,695.462 | 2,183.539 | 1,464.809 |
| Cost of Revenue
| 4,526.3 | 3,309.9 | 3,982.357 | 3,519.578 | 1,848.895 | 1,924.306 | 2,139.47 | 2,364.565 | 2,467.952 | 2,770.889 | 3,079.924 | 2,692.277 | 2,259.143 | 2,148.313 | 1,925.39 | 1,690.494 | 1,380.075 | 932.742 |
| Gross Profit
| 1,488.2 | 2,245.2 | 2,004.14 | 1,961.657 | 1,517.425 | 1,249.853 | 1,555.096 | 1,598.039 | 1,681.442 | 1,863.726 | 2,283.311 | 1,987.149 | 1,839.241 | 1,492.427 | 1,220.726 | 1,004.967 | 803.464 | 532.066 |
| Gross Profit Ratio
| 0.247 | 0.404 | 0.335 | 0.358 | 0.451 | 0.394 | 0.421 | 0.403 | 0.405 | 0.402 | 0.426 | 0.425 | 0.449 | 0.41 | 0.388 | 0.373 | 0.368 | 0.363 |
| Reseach & Development Expenses
| 158.4 | 228.9 | 230.299 | 118.699 | 142.523 | 146.53 | 306.385 | 85.679 | 107.001 | 120.83 | 166.566 | 160.263 | 0 | 128.355 | 110.784 | 77.409 | 51.551 | 30.715 |
| General & Administrative Expenses
| 998.2 | 115.554 | 91.076 | 111.636 | 104.643 | 56.725 | 48.86 | 44.01 | 32.593 | 41.117 | 32.864 | 24.648 | 560.155 | 116.558 | 100.933 | 105.921 | 78.877 | 65.316 |
| Selling & Marketing Expenses
| 0 | 801 | 487.094 | 660.295 | 417.612 | 314.066 | 386.805 | 325.122 | 394.696 | 440.087 | 395.492 | 289.377 | 0 | 342.751 | 267.114 | 184.995 | 127.257 | 66.822 |
| SG&A
| 998.2 | 801 | 578.17 | 771.931 | 522.255 | 370.791 | 435.665 | 369.132 | 427.289 | 481.204 | 428.356 | 314.025 | 560.155 | 459.309 | 368.047 | 290.916 | 206.134 | 132.138 |
| Other Expenses
| 115.8 | 103.2 | 10.775 | 130.131 | 23.725 | 22.621 | 18.865 | 18.445 | 15.271 | 2.244 | 0.923 | 1.704 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 1,156.6 | 1,966.2 | 1,718.336 | 1,776.648 | 1,429.361 | 1,264.399 | 1,497.504 | 1,233.129 | 1,285.597 | 1,429.959 | 1,333.947 | 1,115.775 | 1,055.865 | 777.455 | 616.241 | 434.654 | 322.443 | 203.461 |
| Operating Income
| 331.6 | 283.889 | 290.429 | 315.14 | 111.788 | -11.543 | 62.937 | 42.051 | 35.071 | 26.48 | 690.79 | 626.722 | 783.429 | 714.972 | 604.486 | 570.313 | 481.021 | 328.606 |
| Operating Income Ratio
| 0.055 | 0.051 | 0.049 | 0.057 | 0.033 | -0.004 | 0.017 | 0.011 | 0.008 | 0.006 | 0.129 | 0.134 | 0.191 | 0.196 | 0.192 | 0.212 | 0.22 | 0.224 |
| Total Other Income Expenses Net
| 114.8 | 95.415 | 73.652 | 170.394 | -192.142 | -285.715 | -338.253 | -0.001 | 0.002 | -0.002 | 0.001 | 1.638 | -274.904 | -188.642 | -140.701 | -93.547 | -47.682 | -28.088 |
| Income Before Tax
| 446.4 | 379.3 | 364.081 | 485.534 | -80.355 | -297.258 | -275.316 | 42.05 | 35.073 | 26.478 | 690.791 | 628.36 | 508.525 | 526.33 | 463.785 | 476.767 | 433.34 | 300.518 |
| Income Before Tax Ratio
| 0.074 | 0.068 | 0.061 | 0.089 | -0.024 | -0.094 | -0.075 | 0.011 | 0.008 | 0.006 | 0.129 | 0.134 | 0.124 | 0.145 | 0.147 | 0.177 | 0.198 | 0.205 |
| Income Tax Expense
| 161.5 | 113.6 | -43.161 | -132.12 | 19.639 | -11.5 | 31.602 | -37.041 | 18.084 | -25.129 | 47.822 | 55.268 | 37.753 | 64.149 | 68.196 | 37.251 | 75.244 | 46.682 |
| Net Income
| 284.9 | 265.7 | 407.242 | 617.654 | -99.993 | -285.747 | -306.918 | 79.091 | 16.988 | 51.607 | 642.968 | 573.093 | 470.772 | 462.181 | 395.589 | 439.516 | 358.095 | 253.836 |
| Net Income Ratio
| 0.047 | 0.048 | 0.068 | 0.113 | -0.03 | -0.09 | -0.083 | 0.02 | 0.004 | 0.011 | 0.12 | 0.122 | 0.115 | 0.127 | 0.126 | 0.163 | 0.164 | 0.173 |
| EPS
| 21.31 | 19.87 | 30.47 | 50.04 | -8.1 | -23.16 | -24.87 | -14.88 | 1.48 | 4.51 | 57.17 | 58.8 | 51.22 | 50.63 | 46.69 | 51.99 | 42.36 | 30.19 |
| EPS Diluted
| 21.31 | 19.87 | 30.47 | 50.04 | -8.1 | -23.16 | -24.87 | -14.88 | 1.48 | 4.51 | 57.17 | 58.8 | 51.22 | 50.63 | 46.69 | 51.99 | 42.36 | 30.19 |
| EBITDA
| 596 | 705.2 | 701.399 | 673.978 | 513.117 | 353.302 | 401.264 | 804.405 | 778.085 | 802.003 | 1,343.033 | 1,175.411 | 1,035.629 | 906.01 | 741.896 | 636.641 | 545.78 | 369.213 |
| EBITDA Ratio
| 0.099 | 0.127 | 0.117 | 0.123 | 0.152 | 0.111 | 0.109 | 0.203 | 0.188 | 0.173 | 0.25 | 0.251 | 0.253 | 0.249 | 0.236 | 0.236 | 0.25 | 0.252 |